NCT05598749View on ClinicalTrials.gov

Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study

NACompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

July 3, 2024

Study Completion Date

July 3, 2024

Conditions
Upper Respiratory Tract Infection (URTI)
Interventions
DIETARY_SUPPLEMENT

Placebo

Arabic gum, sucrose and silicon dioxide mix

DIETARY_SUPPLEMENT

Verum

Propolis dry extract ESIT12 and carriers (arabic gum, sucrose and silicon dioxide mix)

Trial Locations (1)

Unknown

UCAM (Universidad Catolica San Antonio de Murcia), Murcia

All Listed Sponsors
lead

Fytexia

INDUSTRY